Torrance, CA (December 1, 2015) – Neoteryx LLC, a microsampling solutions company, today announced that its patent pending Mitra Microsampling Device has been recognized as one of the 100 most technologically significant innovations of 2015 by R&D Magazine in a field that spans medical, industrial, research, consumer, and manufacturing applications. The awards, referred to as the “Oscars of Innovation”, are determined by an independent judging panel and the editors of R&D Magazine.
This Mitra Microsampling Device, based on Volumetric Absorptive Microsampling (VAMS™) technology, is a sampling device that accurately collects a fixed volume (e.g. 10 µL) of blood or other biological fluid, in seconds, while eliminating the volumetric hematocrit bias and spot quality issues typically associated with the dried blood spotting technique. The dried matrix nature of the device enables at-home or remote sampling since the sample can transported to the analysis lab without the need for cold chain or biohazard shipping.
According to Neoteryx’s Senior Marketing Manager, Cathy Cordova, “This award reflects the positive contributions being made by the Mitra Microsampler to the pharmaceutical and clinical diagnostics environments including an improved patient experience from less invasive blood collections, increased profitability of lab operations due to a streamlined pathway, and the ability to collect blood samples anywhere, at any time, by anyone.”
Two device formats are currently available. The clamshell format enables direct, replicate sampling while the 96-well plate is suitable for method development and validation. Primary uses of the device include sample collection for early drug discovery and clinical trials, remote location sampling, pediatric/geriatric blood collections where volumes are limited, as well as a specimen collection for clinical laboratory developed tests.
R&D 100 Winners were announced and recognized at the R&D Technology Conference in Las Vegas on November 13. A list of winning innovations is on the R&D 100 Awards website, http://rd100awards.com/2015-rd-100-award-winners.
# # #
The Mitra Microsampler class I medical device is for direct specimen collection of blood and other biological fluids. It is not specific to any clinical test, and is not for use in diagnostic procedures. Use of the Mitra Microsampler in Laboratory Developed Tests (LDTs) requires further processing including the establishment of performance characteristics and successful validation by the laboratory in a manner consistent with CLIA requirements.
2023 Editorial Note: This original posted press release from 2015 has not been edited, but please note that regulatory status of the Mitra® device was later changed. Please view the disclaimer below, as well as the updated regulatory statement posted in the website footer of the Neoteryx.com website.